Caligan Partners Lp Top Holdings and 13F Report (2024) About Caligan Partners LpInvestment ActivityCaligan Partners Lp has $1.50 billion in total holdings as of June 30, 2024.Caligan Partners Lp owns shares of 26 different stocks, but just 12 companies or ETFs make up 80% of its holdings.Approximately 26.98% of the portfolio was purchased this quarter.About 10.10% of the portfolio was sold this quarter.This quarter, Caligan Partners Lp has purchased 21 new stocks and bought additional shares in 10 stocks.Caligan Partners Lp sold shares of 2 stocks and completely divested from 4 stocks this quarter.Largest Holdings Liquidia $306,406,984Revolution Medicines $182,996,103ABIVAX SA $162,785,237Vaxcyte $119,748,381Xenon Pharmaceuticals $81,004,520 Largest New Holdings this Quarter 156944100 - CG ONCOLOGY INC $60,912,000 Holding00773J202 - SPYRE THERAPEUTICS INC $44,292,726 Holding50180M108 - LB PHARMACEUTICALS INC $34,628,726 Holding78397T202 - SAB BIOTHERAPEUTICS INC $30,514,403 Holding67577R102 - OPUS GENETICS INC $27,641,377 Holding Largest Purchases this Quarter CG ONCOLOGY INC 900,000 shares (about $60.91M)Revolution Medicines 597,808 shares (about $58.14M)SPYRE THERAPEUTICS INC 878,127 shares (about $44.29M)LB PHARMACEUTICALS INC 1,438,070 shares (about $34.63M)SAB BIOTHERAPEUTICS INC 7,967,207 shares (about $30.51M) Largest Sales this Quarter Mineralys Therapeutics 2,298,400 shares (about $62.26M)Tango Therapeutics 1,321,097 shares (about $27.64M) Sector Allocation Over TimeMap of 500 Largest Holdings ofCaligan Partners Lp Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorLQDALiquidia$306,406,9840.0%8,118,89220.4%MedicalRVMDRevolution Medicines$182,996,103$58,136,828 â–²46.6%1,881,70812.2%MedicalABIVAX SA$162,785,237$1,113,500 â–²0.7%1,461,92410.8%SPONSORED ADSPCVXVaxcyte$119,748,381$20,681,581 â–²20.9%2,060,7198.0%MedicalXENEXenon Pharmaceuticals$81,004,520$17,076,445 â–²26.7%1,393,0275.4%MedicalMLYSMineralys Therapeutics$75,111,197$62,263,656 â–¼-45.3%2,772,6545.0%MedicalEXELExelixis$66,619,4070.0%1,553,2624.4%MedicalCG ONCOLOGY INC$60,912,000$60,912,000 â–²New Holding900,0004.1%COMTNGXTango Therapeutics$50,392,054$27,637,349 â–¼-35.4%2,408,7983.4%MedicalTYRATyra Biosciences$48,907,874$12,742,831 â–²35.2%1,276,9683.3%MedicalADMAADMA Biologics$45,559,164$18,416,467 â–²67.9%5,056,5113.0%MedicalSPYRE THERAPEUTICS INC$44,292,726$44,292,726 â–²New Holding878,1272.9%COM NEWLB PHARMACEUTICALS INC$34,628,726$34,628,726 â–²New Holding1,438,0702.3%COM SHSVOR BIOPHARMA INC$34,343,177$17,839,982 â–²108.1%1,925,0662.3%COM NEWSAB BIOTHERAPEUTICS INC$30,514,403$30,514,403 â–²New Holding7,967,2072.0%COM NEWOPUS GENETICS INC$27,641,377$27,641,377 â–²New Holding6,075,0281.8%COMIVAInventiva$27,610,728$16,510,728 â–²148.7%4,974,9061.8%MedicalMBX BIOSCIENCES INC$25,330,412$25,330,412 â–²New Holding848,5901.7%COMAVALO THERAPEUTICS INC$24,410,893$11,249,606 â–²85.5%1,635,0231.6%COM NEWANIKAnika Therapeutics$20,809,3850.0%1,435,1301.4%MedicalMAZE THERAPEUTICS INC$18,356,616$1,933,414 â–²11.8%614,9621.2%COMVERRICA PHARMACEUTICALS INC$4,887,4840.0%923,9100.3%COM SHSSENSEI BIOTHERAPEUTICS INC$3,971,583$3,971,583 â–²New Holding126,0020.3%COM NEWAGIOAgios Pharmaceuticals$3,044,7000.0%90,0000.2%MedicalAURAAura Biosciences$1,537,790$1,537,790 â–²New Holding229,8640.1%MedicalXILIO THERAPEUTICS INC$942,996$942,996 â–²New Holding112,1280.1%COMINHIBRX BIOSCIENCES INC$0$37,411,635 â–¼-100.0%00.0%COMRAPT THERAPEUTICS INC$0$21,825,828 â–¼-100.0%00.0%COM NEWSPRUCE BIOSCIENCES INC$0$1,786,975 â–¼-100.0%00.0%COM NEWELDNEledon Pharmaceuticals$0$839,527 â–¼-100.0%00.0%MedicalShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
